Cargando…

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy

The presence of an immunosuppressive microenvironment can limit the full potential of adoptive T cell immunotherapy. However, specific blockade of the PD-1 immunosuppressive pathway can significantly enhance the function of gene-modified T cells expressing a chimeric antigen receptor (CAR) leading t...

Descripción completa

Detalles Bibliográficos
Autores principales: John, Liza B, Kershaw, Michael H, Darcy, Phillip K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862687/
https://www.ncbi.nlm.nih.gov/pubmed/24353912
http://dx.doi.org/10.4161/onci.26286
_version_ 1782295773445095424
author John, Liza B
Kershaw, Michael H
Darcy, Phillip K
author_facet John, Liza B
Kershaw, Michael H
Darcy, Phillip K
author_sort John, Liza B
collection PubMed
description The presence of an immunosuppressive microenvironment can limit the full potential of adoptive T cell immunotherapy. However, specific blockade of the PD-1 immunosuppressive pathway can significantly enhance the function of gene-modified T cells expressing a chimeric antigen receptor (CAR) leading to enhanced tumor eradication.
format Online
Article
Text
id pubmed-3862687
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-38626872013-12-18 Blockade of PD-1 immunosuppression boosts CAR T-cell therapy John, Liza B Kershaw, Michael H Darcy, Phillip K Oncoimmunology Author's View The presence of an immunosuppressive microenvironment can limit the full potential of adoptive T cell immunotherapy. However, specific blockade of the PD-1 immunosuppressive pathway can significantly enhance the function of gene-modified T cells expressing a chimeric antigen receptor (CAR) leading to enhanced tumor eradication. Landes Bioscience 2013-10-01 2013-10-10 /pmc/articles/PMC3862687/ /pubmed/24353912 http://dx.doi.org/10.4161/onci.26286 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
John, Liza B
Kershaw, Michael H
Darcy, Phillip K
Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
title Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
title_full Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
title_fullStr Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
title_full_unstemmed Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
title_short Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
title_sort blockade of pd-1 immunosuppression boosts car t-cell therapy
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862687/
https://www.ncbi.nlm.nih.gov/pubmed/24353912
http://dx.doi.org/10.4161/onci.26286
work_keys_str_mv AT johnlizab blockadeofpd1immunosuppressionboostscartcelltherapy
AT kershawmichaelh blockadeofpd1immunosuppressionboostscartcelltherapy
AT darcyphillipk blockadeofpd1immunosuppressionboostscartcelltherapy